These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Use of speckle-strain in a multiparametric approach to dyssynchrony imaging. Marwick TH JACC Cardiovasc Imaging; 2011 Apr; 4(4):375-7. PubMed ID: 21492812 [No Abstract] [Full Text] [Related]
23. Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects. Ambardekar AV; Buttrick PM Circ Heart Fail; 2011 Mar; 4(2):224-33. PubMed ID: 21406678 [No Abstract] [Full Text] [Related]
24. Meta-analysis of cell therapy trials for patients with heart failure. Fisher SA; Doree C; Mathur A; Martin-Rendon E Circ Res; 2015 Apr; 116(8):1361-77. PubMed ID: 25632038 [TBL] [Abstract][Full Text] [Related]
25. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction. Zamani P; Akers S; Soto-Calderon H; Beraun M; Koppula MR; Varakantam S; Rawat D; Shiva-Kumar P; Haines PG; Chittams J; Townsend RR; Witschey WR; Segers P; Chirinos JA J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219917 [TBL] [Abstract][Full Text] [Related]
26. M cells in the human heart. Antzelevitch C Circ Res; 2010 Mar; 106(5):815-7. PubMed ID: 20299671 [No Abstract] [Full Text] [Related]
29. Stem cell therapy in heart failure: where do we stand and where are we heading? Pucéat M Heart Fail Monit; 2006; 5(2):44-9. PubMed ID: 16816876 [TBL] [Abstract][Full Text] [Related]
30. Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy. Greene SJ; Epstein SE; Kim RJ; Quyyumi AA; Cole RT; Anderson AS; Wilcox JE; Skopicki HA; Sikora S; Verkh L; Tankovich NI; Gheorghiade M; Butler J J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):283-290. PubMed ID: 26479144 [TBL] [Abstract][Full Text] [Related]
31. Favorable effects of left ventricular reconstruction in patients excluded from the Surgical Treatments for Ischemic Heart Failure (STICH) trial. Dor V; Civaia F; Alexandrescu C; Sabatier M; Montiglio F J Thorac Cardiovasc Surg; 2011 Apr; 141(4):905-16, 916.e1-4. PubMed ID: 21419901 [TBL] [Abstract][Full Text] [Related]
37. Cell therapy for acute myocardial infarction--where do we go from here? Traverse JH; Henry TD J Cardiovasc Transl Res; 2008 Mar; 1(1):64-70. PubMed ID: 20559959 [TBL] [Abstract][Full Text] [Related]
38. A new heart: somatic stem cells and myocardial regeneration. Mullenix PS; Huddleston SJ; Stojadinovic A; Trachiotis GD; Alexander EP J Surg Oncol; 2012 Apr; 105(5):475-80. PubMed ID: 22441899 [TBL] [Abstract][Full Text] [Related]
39. Heterotopic Abdominal Rat Heart Transplantation as a Model to Investigate Volume Dependency of Myocardial Remodeling. Benke K; Sayour AA; Mátyás C; Ágg B; Németh BT; Oláh A; Ruppert M; Hartyánszky I; Szabolcs Z; Radovits T; Merkely B; Szabó G Transplantation; 2017 Mar; 101(3):498-505. PubMed ID: 27906830 [TBL] [Abstract][Full Text] [Related]
40. Stem cell therapy in chronic ischemic heart dysfunction with and without viability. Sánchez PL; Sanz-Ruiz R; Fernández-Santos ME; Villa A; Gutiérrez E; Fernández L; Vázquez S; Lorenzo MJ; Fernández-Avilés F Cardiovasc Hematol Disord Drug Targets; 2010 Sep; 10(3):167-72. PubMed ID: 20678064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]